Effects of octreotide on experimental neurogenic orthostatic hypotension in anaesthetized dogs

Fundamental and Clinical Pharmacology

Volumn 11, Issue 3, 1997, Pages 237-244

  Bordet, R ^a   Verwaerde, P ^b   Tran, M A ^b   Marques, M A ^c   Montastruc, J L ^b   Senard, J M ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Catecholamines; Octreotide; Orthostatic hypotension; Sinoartic denervation; Spectrals analysis

Indexed keywords

OCTREOTIDE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DENERVATION; DOG; FOURIER TRANSFORMATION; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030926876     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00191.x     Document Type: Article

References (30)

1. Akselrod S, Gordon D, Ubel FA et al. Power spectrum analysis of heart rate fluctuations: a quantitative probe to beat-to-beat cardiovascular control. Science 1981;59:178-83
2. Armstrong E, Mathias CJ. The effects of the somatostatin analogue, octreotide, on postural hypotension before and after food ingestion in primary autonomic failure. Clin Auton Res 1991;1:135-40
3. Bannister R, Da Costa DF, Kooner JS et al. Insulin-induced hypotension in autonomic failure in euglycaemia in man. J Physiol 1987;382:36P
4. Bordet R, Benhadjali J, Libersa et al. Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial chronic administration. Clin Neuropharmacol 1994;4:380-83
5. Bordet R, Benhadjali J, Destee A et al. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: A controlled study of acute administration. Clin Neuropharmacol 1995;18:83-9
6. Brown RT, Polinsky RJ, Baucom CE. Euglycemic insulin-induced hypotension in autonomic failure. Clin Neuropharmacol 1989;12:227-31
7. Camboni MG. Octreotide. In: Braga PC, Titobello A, Guslandi M, eds. Drugs in Gastroenterology. New York: Raven Press Ltd, 1991;318-36
8. Conway DR, Djuricin G, Prinz RA. The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow. Surgery 1988;104:1024-30
9. Cooper AM, Braavedt GD, Qamar MI et al. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci 1991;81:169-75
10. Dusl RJ, Anderson DS, Forsythe AB et al. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. Am J Med 1987;83:584-8
11. Galitzky J, Reverte M, Carpene et al. Beta3-adrenoceptors in dog adipose tissues: studies on their involvement in the lipomobilizing effect of catecholamines. J Pharmacol Exp Ther 1993;266:358-66
12. Hedmann AE, Hartikainen JEK, Tahvainen KUO et al. Power spectral analysis of heart rate and blood pressure variability in anaesthetized dogs. Acta Physiol Scand 1992;146:155-64
13. Hoeldtke RD, O'Dorisio TM, Boden G. Treatment of autonomic neuropathy with a somatostin analogue, SMS 201-995. Lancet 1986;2:602-5
14. Hoeldtke RD, Israel BC. Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 1989;68:1051-9
15. Hoeldtke RD, Davis KM, Joseph J. Hemodynamics effects of octreotide in patients with autonomie neuropathy. Circulation 1991;84:168-76
16. Jansen RWMM, Peeters TL, Lenders JWM, Van Lier HJ et al. Somatostatin analog octreotide (SMS 201-995° prevents the decrease in blood pressure after oral glucose loading in the elderly. J Clin Endocrinol Metab 1989;68:752-6
17. Jaspan J, Polonovsky K, Lewis M et al. Reduction in portal vein blood flow by somatostatin. Diabetes 1979;28:888-92
18. Kafka MS, Polinsky RJ, Williams A et al. Alpha-adrenergic receptors in orthostatic hypotension syndromes. Neurology 1984;34:112-25
19. Lacroix JS, Auberson S, Morel DR et al. Vascular control of the pig nasal mucosa: distribution and effect of somatostatin in relation to noradrenaline and neuropeptide Y. Reg Peptides 1992;40:373-87
20. Long JB, Rigamonti DD, Dosaka, K et al. Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system. J Pharmacol Exp Ther 1992;260:1425-32
21. Marin P, Delumeau JC, Tence M et al. Somatostatin potentiates the alpha1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate. Proc Natl Acad Sci USA 1991;88:901620
22. Polinsky RJ, Kopin IJ, Ebert MH et al. Pharmacological distinction of different orthostatic hypotension syndromes. Neurology 1981:31:1-7
23. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(special supplement):78-9
24. Raimbach SJ, Cortelli P, Kooner JS et al. Prevention of glucose-induced hypotension by the somatostatin analogue (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes. Clin Sci 1989;77:623-8
25. Senard JM, Barbe P, Estan L et al. Decreased high-affinity state in platelet alpha2-adrenoceptors from diabetic patients with orthostatic hypotension. J Clin Endocrinol Metab 1990; 71:311-17
26. Senard JM, Chamontin B, Rascol A et al. Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res 1992;2:99-104
27. Senard JM and Montastruc JL. Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996;10:225-33
28. Tavernier G, Damase-Michel C, Portolan G et al. Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation? Naunyn-Schmiedeberg's Arch Pharmacol 1992;345:431-6
29. Valet P, Damase-Michel C, Montastruc JL et al. Plasma catecholamine levels and adrenoceptors after chronic sinoaortic denervation in dogs. Fundam Clin Pharmacol 1989;3: 307-20
30. Verwaerde P, Senard JM, Mazerolles M et al. Spectral analysis of blood pressure and heart rate, catecholamine and neuropeptide Y plasma levels in a new model of neurogenic orthostatic hypotension in dogs. Clin Auton Res 1996; 6:75-82